A prospective, cohort, observational study assessing the impact of whole-cell bacterial immunoprophylaxis in the management of recurrent urinary tract infections in the frail elderly
Latest Information Update: 23 Sep 2021
At a glance
- Drugs Enterococcus-faecalis-FK23/escherichia-coli-vaccine/klebsiella-vaccine/proteus-vulgaris-inactivated-vaccine (Primary)
- Indications Urinary tract infections
- Focus Therapeutic Use
Most Recent Events
- 23 Sep 2021 New trial record
- 15 Sep 2021 Results published in the Vaccine